ArticleCureus2025
Patterns of Distant Organ Metastasis and Risk Factors in Rectal Adenocarcinoma Patients: A Retrospective Cohort Analysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background In this study, we aimed to analyze the metastatic patterns of rectal adenocarcinoma (RAC) to specific organs, assessing the incidence, associated risk factors, and prognostic implications of metastasis. Methodology We conducted a retrospective cohort study utilizing data from the Surveillance, Epidemiology, and End Results database, focusing on RAC patients diagnosed between 2010 and 2018. Analyses were performed to evaluate overall survival (OS) and cancer-specific survival (CSS). Results We included 13,564 patients with RAC. Significant risk factors for metastasis were age <50 years (odds ratio (OR) = 1.168), grade 4 (OR = 2.119), T4 (OR = 1.866), N2 (OR = 4.520), and patients without surgery (OR = 9.71). The median OS and CSS in metastatic RAC were 24 and 25 months, respectively. Variables significantly associated with decreased OS were old age, high-grade tumors, T4, N2, tumors >200 mm, no surgery, and multiple metastatic sites. The variables significantly associated with reduced CSS were old age, high-grade tumors, T4, N2, tumors larger than 200 mm, no surgery, and multiple metastatic sites. Conclusions The liver was the most common organ in which metastasis occurred. Significant risk factors observed in RAC patients for metastasis were age <50 years, grade 4, T4, N2, and patients without surgery. Old age, multiple metastatic sites, high-grade tumors, T4, N2, tumors larger than 200 mm, and no surgery were strongly linked to a lower OS rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.